PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
13-May-2021 Scientists design new drug compound to stop malaria in its tracks Francis Crick Institute
12-May-2021 SOHM, Inc., to focus growth on Rx-to-OTC Switches with private label products Sohm, Inc.
12-May-2021 BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd. BRAIN Biotech AG
12-May-2021 Huma raises $130 million financing to scale its digital health platform for better care and research Huma Therapeutics Limited
12-May-2021 Novasep expands its HPAPI manufacturing capacity in Le Mans for innovative cancer therapies Novasep
12-May-2021 Chiesi launches new virtual learning and support platform for respiratory nurses Chiesi
12-May-2021 New BC Platforms Partnership with Artisan Biomed to Unlock African Access to Precision Medicine BC Platforms
12-May-2021 BIOMEGA GROUP INVESTS IN NEW BIOREFINERY IN DENMARK TO SUPPORT GROWTH IN HUMAN HEALTH & NUTRITION Biomega Group
12-May-2021 FDA grants orphan drug designation for Endogena’s lead program targeting retinitis pigmentosa Endogena Therapeutics Inc.
12-May-2021 Biotage Launches New Microelution Sample Preparation Workstation B3C newswire
12-May-2021 Q BioMed Insider to Invest up to $30M in the Company Q BioMed Inc.
12-May-2021 FDA grants orphan drug designation for Endogena’s lead program targeting retinitis pigmentosa Endogena
12-May-2021 Record sales generated by online business – lockdowns hurt store performance in the second quarter Douglas GmbH
12-May-2021 Epigenomics AG Reports Financial Results for the First Quarter of 2021 Epigenomics AG
12-May-2021 ​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2021 PAION AG
12-May-2021 SYNLAB delivers record growth in Q1 2021 SYNLAB AG
12-May-2021 AEVIS VICTORIA SA: First quarter 2021 consolidated revenue increased to CHF 195.7 million (+0.4% compared to 2020 and +10.4% compared to 2019) AEVIS VICTORIA SA
11-May-2021 MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma MorphoSys AG
11-May-2021 Correction of a release from 11/05/2021, 14:30 CET/CEST - Biotest AG: Annual General Meeting approves dividend distribution Biotest AG
11-May-2021 SMC Accepts AbbVie’s RINVOQ® ▼ (upadacitinib) For Use in Adults with Active Psoriatic Arthritis AbbVie